Dr. Martens Plc (GB:DOCS) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
IngreGrsy Limited has acquired a 38.46% stake in Dr. Martens PLC, as part of a restructure within the Permira V Fund. The transaction, completed on June 12, 2024, sees IngreGrsy Limited taking over from IngreLux S.àr.l. as a major shareholder in the iconic British footwear brand. This significant move could potentially influence the future direction and control of the company.
For further insights into GB:DOCS stock, check out TipRanks’ Stock Analysis page.